Reinert P, Hamberger C, Rahimy M C, Dusseau C, Bernaudin F, Barre J, Tillement J P, Lemerle S
Service de Pédiatrie, Laboratoire Hospitalo-Universitaire de Pharmacologie, Centre Hospitalier Intercommunal, Créteil.
Arch Fr Pediatr. 1988 Mar;45(3):201-3.
Cyclosporin A was used in a 3 1/2 year-old child with dermatomyositis exhibiting severe junctional impairment and intolerance to steroids. After a few weeks, marked clinical improvement was observed allowing a reduction of the doses of steroids. After 9 months, the clinical status was satisfactory: the calcifications had lost their inflammatory characteristics. No side effect of cyclosporin A was observed at the dose used (4.4 mg/kg/d) which maintained effective blood concentrations between 80 and 220 ng/ml.
环孢素A用于一名3岁半患有皮肌炎的儿童,该患儿表现出严重的交界区损害且对类固醇不耐受。几周后,观察到明显的临床改善,使得类固醇剂量得以减少。9个月后,临床状况令人满意:钙化灶已失去其炎症特征。在所使用的剂量(4.4毫克/千克/天)下未观察到环孢素A的副作用,该剂量使有效血药浓度维持在80至220纳克/毫升之间。